{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:56:00Z","timestamp":1771955760931,"version":"3.50.1"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018576","name":"Ten Thousand Talent Plans for Young Top-notch Talents of Yunnan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018576","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"Background<\/jats:title>Although gonadotropin-releasing hormone (GnRH) agonist has been introduced as a beneficial luteal phase support (LPS), the optimal strategy of GnRH agonist remains unclear. This network meta-analysis was therefore performed to determine the comparative efficacy and safety of multiple-dose versus single-dose GnRH agonist protocol for LPS in patients undergoing IVF\/ICSI cycles.<\/jats:p><\/jats:sec>Methods<\/jats:title>We searched relevant studies in PubMed, Embase and the Cochrane Registry of Controlled Trials (CENTRAL) from their inception util to September 2021. Live birth, clinical pregnancy rate, multiple pregnancy rate, and clinical abortion rate was evaluated. Pairwise and network meta-analysis were conducted using RevMan and ADDIS based on random-effects model, respectively. Moreover, the prioritization of protocols based on ranking probabilities for different outcomes were performed.<\/jats:p><\/jats:sec>Results<\/jats:title>Sixteen RCTs met our eligibility criteria. Pairwise meta-analysis showed that multiple-dose protocol of GnRH agonist was effective for increasing live birth rate (OR 1.80, 95% CI 1.15 to 2.83, p<\/jats:italic>=0.01) and clinical pregnancy rate (OR 1.89, 95% CI 1.01 to 3.56, p<\/jats:italic>=0.05) as well as decreasing clinical abortion rate (OR 0.55, 95% CI 0.34 to 0.90, p<\/jats:italic>=0.02). Meanwhile, single-dose protocol of GnRH agonist was effective for increasing clinical pregnancy rate (OR 1.45, 95% CI 1.11 to 1.89, p<\/jats:italic>=0.007) and multiple pregnancy rate (OR 2.55, 95% CI 1.12 to 5.78, p<\/jats:italic>=0.03). However, network meta-analysis only confirmed that multiple-dose protocol of GnRH agonist was the best efficacious strategy for live birth rate (OR 2.04, 95% CrI 1.19 to 3.93) and clinical pregnancy rate (OR 2.10, 95% CrI 1.26 to 3.54).<\/jats:p><\/jats:sec>Conclusion<\/jats:title>Based on the results of NMA, multiple-dose protocol may be the optimal strategy for patients undergoing IVF\/ICSI cycles owing to its advantage in increasing live birth and clinical pregnancy rate. Moreover, single-dose protocol may be the optimal strategy for improving multiple pregnancy rate. However, with the limitations, more RCTs are required to confirm our findings.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.802688","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T04:51:31Z","timestamp":1648702291000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Single-Dose Versus Multiple-Dose GnRH Agonist for Luteal-Phase Support in Women Undergoing IVF\/ICSI Cycles: A Network Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.3389","volume":"13","author":[{"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanzhi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengmei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangjie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youhui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushi","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2021.03.039","article-title":"International Committee for Monitoring Assisted Reproductive Technologies (ICMART): World Report on Assisted Reproductive Technologies, 2013","volume":"116","author":"Banker","year":"2021","journal-title":"Fertil Steril"},{"key":"B2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000501204","article-title":"Effect of Gonadotrophin-Releasing Hormone Agonist Addition for Luteal Support on Pregnancy Outcome In Vitro Fertilization\/Intracytoplasmic Sperm Injection Cycles: A Meta-Analysis Based on Randomized Controlled Trials","volume":"85","author":"Ma","year":"2020","journal-title":"Gynecol Obstet Invest"},{"key":"B3","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.1016\/S1472-6483(10)61065-6","article-title":"The Luteal Phase After 3 Decades of IVF: What do We Know","volume":"19","author":"Fatemi","year":"2009","journal-title":"Reprod BioMed Online"},{"key":"B4","doi-asserted-by":"publisher","first-page":"Cd009154","DOI":"10.1002\/14651858.CD009154.pub3","article-title":"Luteal Phase Support for Assisted Reproduction Cycles","volume":"2015","author":"van der Linden","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/17.9.2287","article-title":"Luteal Phase Support in Infertility Treatment: A Meta-Analysis of the Randomized Trials","volume":"17","author":"Pritts","year":"2002","journal-title":"Hum Reprod"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2014.964638","article-title":"Which Luteal Phase Support is Better for Each IVF Stimulation Protocol to Achieve the Highest Pregnancy Rate? A Superiority Randomized Clinical Trial","volume":"30","author":"Gizzo","year":"2014","journal-title":"Gynecol Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12958-021-00782-5","article-title":"Luteal Phase Support for In Vitro Fertilization\/Intracytoplasmic Sperm Injection Fresh Cycles: A Systematic Review and Network Meta-Analysis","volume":"19","author":"Wu","year":"2021","journal-title":"Reprod Biol Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/aogs.12770","article-title":"Clinical Use of Progesterone in Infertility and Assisted Reproduction","volume":"94","author":"Ciampaglia","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/del072","article-title":"GnRH Agonist as Luteal Phase Support in Assisted Reproduction Technique Cycles: Results of a Pilot Study","volume":"21","author":"Pirard","year":"2006","journal-title":"Hum Reprod"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151388","article-title":"Subcutaneous Progesterone Is Effective and Safe for Luteal Phase Support in IVF: An Individual Patient Data Meta-Analysis of the Phase III Trials","volume":"11","author":"Doblinger","year":"2016","journal-title":"PloS One"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.5935\/1518-0557.20180018","article-title":"Oral Dydrogesterone vs. Vaginal Progesterone Capsules for Luteal-Phase Support in Women Undergoing Embryo Transfer: A Systematic Review and Meta-Analysis","volume":"22","author":"Barbosa","year":"2018","journal-title":"JBRA Assist Reprod"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.08.019","article-title":"Simplifying Luteal Phase Support in Stimulated Assisted Reproduction Cycles","volume":"110","author":"Fatemi","year":"2018","journal-title":"Fertil Steril"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/16.8.1671","article-title":"Continuous Administration of Gonadotrophin-Releasing Hormone Agonist During the Luteal Phase in IVF","volume":"16","author":"Fujii","year":"2001","journal-title":"Hum Reprod"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh235","article-title":"Enhancement of Embryo Developmental Potential by a Single Administration of GnRH Agonist at the Time of Implantation","volume":"19","author":"Tesarik","year":"2004","journal-title":"Hum Reprod"},{"key":"B15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1477-7827-8-107","article-title":"Administration of Single-Dose GnRH Agonist in the Luteal Phase in ICSI Cycles: A Meta-Analysis","volume":"8","author":"Oliveira","year":"2010","journal-title":"Reprod Biol Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2019.8251","article-title":"Administration Effects of Single-Dose GnRH Agonist for Luteal Support in Females Undertaking IVF\/ICSI Cycles: A Meta-Analysis of Randomized Controlled Trials","volume":"19","author":"Song","year":"2020","journal-title":"Exp Ther Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmr029","article-title":"Increased Live Birth Rates With GnRH Agonist Addition for Luteal Support in ICSI\/IVF Cycles: A Systematic Review and Meta-Analysis","volume":"17","author":"Kyrou","year":"2011","journal-title":"Hum Reprod Update"},{"key":"B18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ejogrb.2014.08.026","article-title":"The Addition of Gonadotrophin Releasing Hormone Agonist to Routine Luteal Phase Support in Intracytoplasmic Sperm Injection and Embryo Transfer Cycles: A Randomized Clinical Trial","volume":"182","author":"Yildiz","year":"2014","journal-title":"Eur J Obstetrics Gynecol Reprod Biol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"300060520926026","DOI":"10.1177\/0300060520926026","article-title":"Multiple-Dose Versus Single-Dose Gonadotropin-Releasing Hormone Agonist After First In Vitro Fertilization Failure Associated With Luteal Phase Deficiency: A Randomized Controlled Trial","volume":"48","author":"Qu","year":"2020","journal-title":"J Int Med Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12958-019-0543-2","article-title":"GnRH Agonists to Sustain the Luteal Phase in Antagonist IVF Cycles: A Randomized Prospective Trial","volume":"17","author":"Fusi","year":"2019","journal-title":"Reprod Biol Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.18502\/ijrm.v19i7.9475","article-title":"Effects of Multiple Doses of Gonadotropin-Releasing Hormone Agonist on the Luteal-Phase Support in Assisted Reproductive Cycles: A Clinical Trial Study","volume":"19","author":"Eftekhar","year":"2021","journal-title":"Int J Reprod BioMed"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.4103\/0974-1208.106341","article-title":"Evaluation of the Impact of Gonadotropin-Releasing Hormone Agonist as an Adjuvant in Luteal-Phase Support on IVF Outcome","volume":"5","author":"Inamdar","year":"2012","journal-title":"J Hum Reprod Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.5935\/1518-0557.20200077","article-title":"Efficacy of Daily GnRH Agonist for Luteal Phase Support Following GnRH Agonist Triggered ICSI Cycles Versus Conventional Strategy: A Randomized Controlled Trial","volume":"25","author":"Salehpour","year":"2021","journal-title":"JBRA Assist Reprod"},{"key":"B24","doi-asserted-by":"publisher","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 Explanation and Elaboration: Updated Guidance and Exemplars for Reporting Systematic Reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2385","article-title":"The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-Analyses of Health Care Interventions: Checklist and Explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Internal Med"},{"key":"B26","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [Updated March 2011]","author":"Higgins","year":"2011"},{"key":"B27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2393-13-12","article-title":"Risk Factors for Antepartum Stillbirth and the Influence of Maternal Age in New South Wales Australia: A Population Based Study","volume":"13","author":"Gordon","year":"2013","journal-title":"BMC Pregnancy Childbirth"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181f903f8","article-title":"Prepregnancy Risk Factors for Antepartum Stillbirth in the United States","volume":"116","author":"Reddy","year":"2010","journal-title":"Obstet Gynecol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's Tool for Assessing Risk of Bias in Randomised Trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"B30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1471-2288-11-41","article-title":"Quantifying, Displaying and Accounting for Heterogeneity in the Meta-Analysis of RCTs Using Standard and Generalised Q Statistics","volume":"11","author":"Bowden","year":"2011","journal-title":"BMC Med Res Methodol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186","article-title":"Quantifying Heterogeneity in a Meta-Analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.dss.2012.10.005","article-title":"ADDIS: A Decision Support System for Evidence-Based Medicine","volume":"55","author":"van Valkenhoef","year":"2013","journal-title":"Decis Support Syst"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-159-2-201307160-00008","article-title":"Conceptual and Technical Challenges in Network Meta-Analysis","volume":"159","author":"Cipriani","year":"2013","journal-title":"Ann Intern Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2307\/1390675","article-title":"General Methods for Monitoring Convergence of Iterative Simulations","volume":"7","author":"Brooks","year":"1998","journal-title":"J Comput Graphi Stat"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1080\/10543406.2014.971170","article-title":"A Bayesian Nonlinear Mixed-Effects Regression Model for the Characterization of Early Bactericidal Activity of Tuberculosis Drugs","volume":"25","author":"Burger","year":"2015","journal-title":"J\u00a0Biopharm Stat"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3767","article-title":"Checking Consistency in Mixed Treatment Comparison Meta-Analysis","volume":"29","author":"Dias","year":"2010","journal-title":"Stat Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1328","article-title":"Ranking Crop Species Using Mixed Treatment Comparisons","volume":"10","author":"Albert","year":"2019","journal-title":"Res Synth Methods"},{"key":"B38","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1053\/j.gastro.2015.06.006","article-title":"Comparative Effectiveness of Pharmacological Interventions for Severe Alcoholic Hepatitis: A Systematic Review and Network Meta-Analysis","volume":"149","author":"Singh","year":"2015","journal-title":"Gastroenterology"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1157\/13101085","article-title":"Practical Considerations on Detection of Publication Bias","volume":"20","author":"Palma Perez","year":"2006","journal-title":"Gac Sanit"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2009.10.022","article-title":"Single Dose GnRH Agonist Administration in the Luteal Phase of Assisted Reproduction Cycles: Is the Effect Dependent on the Type of GnRH Analogue Used for Pituitary Suppression","volume":"20","author":"Ata","year":"2010","journal-title":"Reprod BioMed Online"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dem421","article-title":"GnRH Agonist Protocol Administration in the Luteal Phase in ICSI-ET Cycles Stimulated With the Long GnRH Agonist Protocol: A Randomized, Controlled Double Blind Study","volume":"23","author":"Ata","year":"2008","journal-title":"Hum Reprod"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2009.04.001","article-title":"Single-Dose GnRH Agonist Administration in the Luteal Phase of GnRH Antagonist Cycles: A Prospective Randomized Study","volume":"19","author":"Isik","year":"2009","journal-title":"Reprod BioMed Online"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/S1028-4559(09)60297-7","article-title":"Beneficial Effect of Luteal-Phase Gonadotropin-Releasing Hormone Agonist Administration on Implantation Rate After Intracytoplasmic Sperm Injection","volume":"48","author":"Razieh","year":"2009","journal-title":"Taiwan J Obstet Gynecol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s43043-020-00030-7","article-title":"Effects of Gonadotropin-Releasing Hormone Agonist (GnRH-A) as Luteal Phase Support in Intracytoplasmic Sperm Injection (ICSI) Cycles: A Randomized Controlled Trial","volume":"25","author":"Saharkhiz","year":"2020","journal-title":"Middle East Fertil Soc J"},{"key":"B45","first-page":"96","article-title":"Effect of Administration of Single Dose GnRH Agonist in Luteal Phase on Outcome of ICSI-ET Cycles in Women With Previous History of IVF\/ICSI Failure: A Randomized Controlled Trial","volume":"16","author":"Zafardoust","year":"2015","journal-title":"J Reprod Infertil"},{"key":"B46","doi-asserted-by":"publisher","first-page":"727569","DOI":"10.1155\/2015\/727569","article-title":"Contribution to More Patient-Friendly ART Treatment: Efficacy of Continuous Low-Dose GnRH Agonist as the Only Luteal Support-Results of a Prospective, Randomized, Comparative Study","volume":"2015","author":"Pirard","year":"2015","journal-title":"Int J Endocrinol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1080\/14647270701704768","article-title":"Luteal Phase Support With GnRH-A Improves Implantation and Pregnancy Rates in IVF Cycles With Endometrium of